-
1 Comment
Shanghai MicroPort Endovascular MedTech Co., Ltd is currently in a long term uptrend where the price is trading 34.7% above its 200 day moving average.
From a valuation standpoint, the stock is 362.1% more expensive than other stocks from the Healthcare sector with a price to sales ratio of 44.5.
Shanghai MicroPort Endovascular MedTech Co., Ltd's total revenue rose by 64.9% to $142M since the same quarter in the previous year.
Its net income has increased by 78.7% to $52M since the same quarter in the previous year.
Finally, its free cash flow grew by 182.2% to $67M since the same quarter in the previous year.
Based on the above factors, Shanghai MicroPort Endovascular MedTech Co., Ltd gets an overall score of 4/5.
| ISIN | CNE100003MJ5 |
|---|---|
| Sector | Healthcare |
| Industry | Medical Devices |
| Exchange | SHG |
| CurrencyCode | CNY |
| Market Cap | 11B |
|---|---|
| PE Ratio | 21.11 |
| Target Price | 148.57 |
| Beta | 0.38 |
| Dividend Yield | None |
Shanghai MicroPort Endovascular MedTech Co., Ltd. engages in the research and development, manufacturing, and sale of aortic and peripheral vascular medical devices in China and internationally. The company's products include branched aortic stent graft system, thoracic stent graft system, abdominal aortic stent graft and delivery system, bifurcated stent graft system, and other stent graft system in surgical operation, as well as accessories, such as balloon inflation catheter. Shanghai MicroPort Endovascular MedTech Co., Ltd. was incorporated in 2012 and is based in Shanghai, the People's Republic of China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 688016.SHG using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
